ADIRA FOUNDATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2018

Legal Domicile

Principal Officer

DR CYNTHIA GOMEZ

Phone

8774260712

Tax Period

2022-01-01 to 2022-12-31

ADIRA FOUNDATION, founded in 2018, is a small nonprofit that reported $191K in total revenue in fiscal year 2022. Revenue fell 82% from the prior year — a significant decline worth monitoring. Expenses of $2.2M exceeded revenue, resulting in a 1036% operating deficit.

Mission

TO INVEST IN BETTER LIVES FOR PEOPLE WITH NEURODEGENERATIVE DISEASES, IN ADIRA'S EARLY YEARS, WE WILL FOCUS PRINCIPALLY, THOUGH NOT EXCLUSIVELY, ON FIVE NEURODEGENERATIVE DISEASES: ALS, ALZHEIMER'S AND RELATED DEMENTIAS, HUNTINGTON'S DISEASE, MULTIPLE SCLEROSIS, AND PARKINSON'S DISEASE. AT ADIRA WE ACCELERATE THE DESIGN AND FUNDING OF BETTER, MORE INTEGRATED HELP FOR PEOPLE WHO NEED IT NOW. WE ASSEMBLE A HANDFUL OF DISEASES THAT STRUGGLE WITH MANY OF THE SAME BIG THINGS. WE TAKE THEM OUT OF ISOLATION WHERE THEY'RE DEFINED NOT BY THEIR DIAGNOSIS BUT BY THEIR STRUGGLE. FROM A BIRD'S-EYE VIEW, WE SEE THE COMMON THEMES AND TRENDS. WE SPEAK WITH PEOPLE GOING THROUGH THIS JOURNEY TO DESIGN BETTER PROGRAMS WITH THEM, NOT JUST FOR THEM. THEN WE FUND THOSE BIGGER, COMMON PROBLEMS WITH WHICH THEY SAY THEY NEED THE MOST HELP. SOME EXAMPLES OF OUR WORK TO DATE FOCUS ON CAREGIVING, NAVIGATION OF DIFFERENT SERVICES, DISABILITY, EQUITY, MEASUREMENTS FOR QUALITY OF LIFE, AND MENTAL HEALTH.

Program Service Accomplishments

Program 1

Expenses: $1,418,221 Revenue: $35,302

ADIRA FINANCED GRANTS TO QUALIFIED NON-PROFITS TO INVEST IN BETTER LIVES FOR PEOPLE WITH NEURODEGENERATIVE DISEASES, STARTING WITH FIVE COMMUNITIES: ALS, ALZHEIMERS AND RELATED DEMENTIAS...

ADIRA FINANCED GRANTS TO QUALIFIED NON-PROFITS TO INVEST IN BETTER LIVES FOR PEOPLE WITH NEURODEGENERATIVE DISEASES, STARTING WITH FIVE COMMUNITIES: ALS, ALZHEIMERS AND RELATED DEMENTIAS, HUNTINGTONS, MULTIPLE SCLEROSIS, AND PARKINSONS. In 2022, we implemented a third round of competitive grantmaking on three key topics: simplifying clinical research, preparing for financial threats, and helping people thrive again. Total grants paid for 2022 were $281,521. We managed this in addition to monitoring our ongoing grant activities from previous years. Finally, we piloted a series of three neurodegenerative disease (ND) congress events bringing those with lived expertise in conversation with career experts to design new grants together. Unfortunately, due to a lack of financing momentum, we were forced to enter dissolution at the end of the 2022.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $140,363

Program Service Revenue $0

Investment Income $15,247

Other Revenue $35,302

TOTAL REVENUE $190,912

Expense Breakdown

Grants Paid $316,521

Salaries & Benefits $744,138

Fundraising Expenses $367,069

Program Expenses $1,418,221

Other Expenses $1,108,756

TOTAL EXPENSES $2,169,415

Year-over-Year Comparison

	2022	2021	Change
Revenue	$190,912	$1,074,322	-0.8%
Expenses	$2,169,415	$1,281,083	+0.7%
Net Income	$-1,978,503	$-206,761	+8.6%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$244,878

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
GREG SMILEY - UNTIL 121622	Founder/CEO	40.00	Officer	$217,878	$27,000	$244,878
MARILYN SPINNER -UNTIL 10522	Chief Dev. & External Affairs Officer	40.00		$114,480	$26,844	$141,324
DR CYNTHIA GOMEZ	Chair	2.00	Officer Director	$0	$0	$0
ALAN J ABRAMSOM	Vice President	2.00	Officer Director	$0	$0	$0
TODD EVENSON	Treasurer	2.00	Officer Director	$0	$0	$0
Cheryl Sullivan Staveley	Secretary	2.00	Officer Director	$0	$0	$0
LAURA HANEN	Director	1.00	Director	$0	$0	$0
ALAN HUTSON	Director	1.00	Director	$0	$0	$0
IAN KREMER	Director	1.00	Director	$0	$0	$0
ZEN MELESSE	Director	1.00	Director	$0	$0	$0
KANDY FERREE	Director	1.00	Director	$0	$0	$0
BRUCE PACKETT - UNTIL 1122	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$190,912	$2,169,415	$46,085	$-1,978,503
2021	$1,074,322	$1,281,083	$2,118,169	$-206,761
2020	$43,222	$1,929,417	$2,916,341	$-1,886,195
2019	$3,899	$1,702,442	$142,611	$-1,698,543